Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3100361rdf:typepubmed:Citationlld:pubmed
pubmed-article:3100361lifeskim:mentionsumls-concept:C0024501lld:lifeskim
pubmed-article:3100361lifeskim:mentionsumls-concept:C0025914lld:lifeskim
pubmed-article:3100361lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:3100361lifeskim:mentionsumls-concept:C0018271lld:lifeskim
pubmed-article:3100361lifeskim:mentionsumls-concept:C0020684lld:lifeskim
pubmed-article:3100361lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:3100361lifeskim:mentionsumls-concept:C1155900lld:lifeskim
pubmed-article:3100361lifeskim:mentionsumls-concept:C1160520lld:lifeskim
pubmed-article:3100361lifeskim:mentionsumls-concept:C0237477lld:lifeskim
pubmed-article:3100361lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:3100361pubmed:issue2lld:pubmed
pubmed-article:3100361pubmed:dateCreated1987-3-18lld:pubmed
pubmed-article:3100361pubmed:abstractTextThe concentration of hypoxanthine in mouse follicular fluid has been estimated to be 2-4 mM, and although this concentration maintains meiotic arrest in fully grown mouse oocytes in vitro, oocyte maturation in vivo is not induced by a decrease in the concentration of this purine in follicular fluid (J. J. Eppig, P. F. Ward-Bailey, and D. L. Coleman, Biol. Reprod. 33, 1041-1049, 1985). In the present study, the effect of 2 mM hypoxanthine on oocyte growth and development in vitro was assessed and the ability of gonadotropins to stimulate oocyte maturation in the continued presence of hypoxanthine was determined. Oocyte-granulosa cell complexes were isolated from 10- to 11-day-old mice and cultured in the presence or absence of 2 mM hypoxanthine. Oocytes from 10- to 11-day-old mice are in mid-growth phase and, without further development, are incompetent of undergoing meiotic maturation. During a 12-day culture period the granulosa cell-enclosed oocytes approximately doubled in size and, regardless of the presence or absence of hypoxanthine, 50-70% developed competence to undergo germinal vesicle breakdown (GVBD). Hypoxanthine promoted the continued association of oocytes with their companion granulosa cells during the 12-day culture period, and therefore had a beneficial effect on oocyte development. Most of the oocytes that acquired GVBD competence in the absence of hypoxanthine underwent spontaneous GVBD. In contrast, 95% of the GVBD-competent oocytes were maintained in meiotic arrest by hypoxanthine. Following withdrawal of the hypoxanthine after the 12-day culture, 75% of the GVBD-competent oocytes underwent GVBD. These results show that hypoxanthine, and/or its metabolites, maintains meiotic arrest in oocytes that grow and acquire GVBD competence in vitro. Follicle-stimulating hormone (FSH), but not luteinizing hormone or human chorionic gonadotropin, induced oocyte GVBD in the continued presence of hypoxanthine. FSH stimulated oocyte maturation at a significantly (P less than 0.01) higher frequency than coculture of the granulosa cell-denuded oocytes with granulosa cells in the continued presence of hypoxanthine. FSH did not induce the maturation of denuded oocytes cocultured with granulosa cells.(ABSTRACT TRUNCATED AT 400 WORDS)lld:pubmed
pubmed-article:3100361pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3100361pubmed:languageenglld:pubmed
pubmed-article:3100361pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3100361pubmed:citationSubsetIMlld:pubmed
pubmed-article:3100361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3100361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3100361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3100361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3100361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3100361pubmed:statusMEDLINElld:pubmed
pubmed-article:3100361pubmed:monthFeblld:pubmed
pubmed-article:3100361pubmed:issn0012-1606lld:pubmed
pubmed-article:3100361pubmed:authorpubmed-author:EppigJ JJJlld:pubmed
pubmed-article:3100361pubmed:authorpubmed-author:DownsS MSMlld:pubmed
pubmed-article:3100361pubmed:issnTypePrintlld:pubmed
pubmed-article:3100361pubmed:volume119lld:pubmed
pubmed-article:3100361pubmed:ownerNLMlld:pubmed
pubmed-article:3100361pubmed:authorsCompleteYlld:pubmed
pubmed-article:3100361pubmed:pagination313-21lld:pubmed
pubmed-article:3100361pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:3100361pubmed:meshHeadingpubmed-meshheading:3100361-...lld:pubmed
pubmed-article:3100361pubmed:meshHeadingpubmed-meshheading:3100361-...lld:pubmed
pubmed-article:3100361pubmed:meshHeadingpubmed-meshheading:3100361-...lld:pubmed
pubmed-article:3100361pubmed:meshHeadingpubmed-meshheading:3100361-...lld:pubmed
pubmed-article:3100361pubmed:meshHeadingpubmed-meshheading:3100361-...lld:pubmed
pubmed-article:3100361pubmed:meshHeadingpubmed-meshheading:3100361-...lld:pubmed
pubmed-article:3100361pubmed:meshHeadingpubmed-meshheading:3100361-...lld:pubmed
pubmed-article:3100361pubmed:meshHeadingpubmed-meshheading:3100361-...lld:pubmed
pubmed-article:3100361pubmed:meshHeadingpubmed-meshheading:3100361-...lld:pubmed
pubmed-article:3100361pubmed:meshHeadingpubmed-meshheading:3100361-...lld:pubmed
pubmed-article:3100361pubmed:meshHeadingpubmed-meshheading:3100361-...lld:pubmed
pubmed-article:3100361pubmed:meshHeadingpubmed-meshheading:3100361-...lld:pubmed
pubmed-article:3100361pubmed:meshHeadingpubmed-meshheading:3100361-...lld:pubmed
pubmed-article:3100361pubmed:year1987lld:pubmed
pubmed-article:3100361pubmed:articleTitleThe effect of hypoxanthine on mouse oocyte growth and development in vitro: maintenance of meiotic arrest and gonadotropin-induced oocyte maturation.lld:pubmed
pubmed-article:3100361pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3100361pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3100361lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3100361lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3100361lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3100361lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3100361lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3100361lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3100361lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3100361lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3100361lld:pubmed